Table 1.
Clinicopathological Feature | Number of Patients (%) |
---|---|
Sex | |
Female | 7 (26.9) |
Male | 19 (73.1) |
Age | |
Median | 68 |
Range | 51–87 |
Tumour location | |
Ascending colon | 5 (19.2) |
Rectum | 1 (3.8) |
Sigmoid | 18 (69.2) |
Transverse colon | 2 (7.7) |
Tumour histological type | |
Adenocarcinoma NOS | 20 (76.9) |
Adenocarcinoma with mucinous component | 4 (15.4) |
Mucinous adenocarcinoma | 2 (7.7) |
Tumour grade (WHO) | |
Low | 26 (100) |
Tumour TNM | |
pT1 N0 | 3 (11.5) |
pT2 N0 | 5 (19.2) |
pT3 N0 | 7 (26.9) |
pT3 N1 | 4 (15.4) |
pT3(m) N0 | 3 (11.5) |
pT4a N0 | 1 (3.8) |
pT4a N1 | 3 (11.5) |
Tumour stage | |
I | 8 (30.8) |
IIA | 10 (38.5) |
IIB | 1 (3.8) |
IIIB | 6 (23.1) |
IIIC | 1 (3.8) |
Follow-up, median in years (range) | 2 (0–4.75) |
Chemotherapy for CRC | 5 (19.2) |
CRC, colorectal cancer; NOS, not otherwise specified.